{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:09:06Z","timestamp":1788480546190,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jacl.2025.03.006","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T08:05:02Z","timestamp":1742285102000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Improvement of retinal microvascular function after initiation of lipid-lowering therapy with PCSK9 inhibitors - An observational study"],"prefix":"10.1016","author":[{"given":"Matthias P.","family":"N\u00e4gele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9897-4674","authenticated-orcid":false,"given":"Yannik","family":"Raemy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Kreysing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Barthelmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Ruschitzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas J.","family":"Flammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Sudano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2025.03.006_bib0001","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-2000-13209","article-title":"Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions","volume":"26","author":"Landmesser","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jacl.2025.03.006_bib0002","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/1741826711398430","article-title":"Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Reriani","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jacl.2025.03.006_bib0003","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacl.2018.07.015","article-title":"Retinal microvascular dysfunction in hypercholesterolemia","volume":"12","author":"Nagele","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2025.03.006_bib0004","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2025.03.006_bib0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.thromres.2020.07.049","article-title":"Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy","volume":"194","author":"Di Minno","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacl.2025.03.006_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2023.104513","article-title":"Chronic PCSK9 inhibitor therapy leads to sustained improvements in endothelial function, arterial stiffness, and microvascular function","volume":"148","author":"Schremmer","year":"2023","journal-title":"Microvasc Res"},{"key":"10.1016\/j.jacl.2025.03.006_bib0007","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00592-021-01703-z","article-title":"Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting","volume":"58","author":"Scicali","year":"2021","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jacl.2025.03.006_bib0008","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jacl.2018.02.004","article-title":"Improved endothelial function after short-term therapy with evolocumab","volume":"12","author":"Maulucci","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2025.03.006_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.athplu.2022.07.001","article-title":"Smoking and diabetes attenuate beneficial effects of PSCK9 inhibitors on arterial wall properties in patients with very high lipoprotein levels","volume":"50","author":"Rehberger","year":"2022","journal-title":"Atheroscler Plus"},{"key":"10.1016\/j.jacl.2025.03.006_bib0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2025.03.006_bib0011","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/eurheartj\/ehx565","article-title":"Retinal microvascular dysfunction in heart failure","volume":"39","author":"Nagele","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2025.03.006_bib0012","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1160\/TH11-11-0810","article-title":"Assessing vascular function using dynamic retinal diameter measurements: a new insight on the endothelium","volume":"107","author":"Heitmar","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacl.2025.03.006_bib0013","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/S0161-6420(99)90525-0","article-title":"Methods for evaluation of retinal microvascular abnormalities associated with hypertension\/sclerosis in the Atherosclerosis Risk in Communities Study","volume":"106","author":"Hubbard","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jacl.2025.03.006_bib0014","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93617-7","article-title":"Normative data and standard operating procedures for static and dynamic retinal vessel analysis as biomarker for cardiovascular risk","volume":"11","author":"Streese","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacl.2025.03.006_bib0015","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/bjo.84.11.1285","article-title":"Evaluation of the Zeiss retinal vessel analyser","volume":"84","author":"Polak","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jacl.2025.03.006_bib0016","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.112.093245","article-title":"The assessment of endothelial function: from research into clinical practice","volume":"126","author":"Flammer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2025.03.006_bib0017","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.110.956490","article-title":"Acetaminophen increases blood pressure in patients with coronary artery disease","volume":"122","author":"Sudano","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2025.03.006_bib0018","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","article-title":"Expert consensus document on arterial stiffness: methodological issues and clinical applications","volume":"27","author":"Laurent","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2025.03.006_bib0019","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0b013e328353e523","article-title":"Evaluating interventions to reduce central aortic pressure, arterial stiffness and morbidity\u2013mortality","volume":"30","author":"Williams","year":"2012","journal-title":"J Hypertension"},{"key":"10.1016\/j.jacl.2025.03.006_bib0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11883-016-0604-3","article-title":"Statins and their effect on PCSK9-impact and clinical relevance","volume":"18","author":"Taylor","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2025.03.006_bib0021","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2025.03.006_bib0022","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2025.03.006_bib0023","doi-asserted-by":"crossref","first-page":"e500","DOI":"10.1111\/j.1755-3768.2011.02154.x","article-title":"Statins affect ocular microcirculation in patients with hypercholesterolaemia","volume":"89","author":"Terai","year":"2011","journal-title":"Acta Ophthalmol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425000595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425000595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T04:09:39Z","timestamp":1747454979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425000595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":23,"alternative-id":["S1933287425000595"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.03.006","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of retinal microvascular function after initiation of lipid-lowering therapy with PCSK9 inhibitors - An observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}